Dr. Justin Anthony Mauldin, MD

Dr. Mauldin practices at Cape Canaveral Hospital in Cocoa Beach, Florida, part of Health First.

Dr. Mauldin's NPI, 1821404500, was assigned on July 2, 2014. Dr. Mauldin holds Florida license ME 131802.

Dr. Mauldin's primary practice is Cape Canaveral Hospital, at 701 W Cocoa Beach Causeway, Cocoa Beach, FL 32931 in Brevard County. The practice phone is (321) 799-7111.

Dr. Mauldin's primary practice is Cape Canaveral Hospital in Cocoa Beach, Florida, part of Health First. Dr. Mauldin is also affiliated with Viera Hospital. The medical group on file is Brevard Physician Associates. Dmand AI also links Dr. Mauldin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mauldin practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Mauldin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Mauldin is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Mauldin is licensed in Florida.

CMS data shows 1,227 Medicare services from Dr. Mauldin across 5 procedure codes in 2024, for 831 Medicare patients. Medicare paid $111,718 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 831 Medicare patients who saw Dr. Mauldin in 2024. The largest group is 75 to 84, with 303 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mauldin's median patient age at 64, with 58% women.

In 2024, Dr. Mauldin wrote 440 Medicare Part D claims for 309 patients. 96% of them were for generic drugs. CMS names the drug for 323 of them, across 13 drugs with 11 or more claims each, at $1,722 in total drug cost. In 2023, CMS named 279 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mauldin for performance year 2024, reported as part of a group. Dr. Mauldin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Mauldin from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $12.

Dr. Mauldin is in network with 4 carriers, including Excellus BlueCross BlueShield, CMS Medicare and GA State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.